Featured Articles

1. Diving Into The Intricacies Of An Approach To Continuous Flow 2/24/2022

   Ajinomoto Bio-Pharma's Dr. Bert Metten fields questions on continuous flow, including scale-up parameters, modeling approaches, reactor design and reaction optimization.

2. Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement With AstraZeneca To Include Drug Product Manufacturing 3/30/2021

   Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, announced a manufacturing agreement expansion with AstraZeneca to include drug product manufacturing.

3. Ajinomoto Bio-Pharma Services Completes Acquisition Of Granules OmniChem Joint Venture In India 6/2/2020

   Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that it has completed the acquisition of Granules OmniChem Private Limited, purchasing the remaining 50 percent ownership interest from its joint venture partner, Granules India Limited.

4. Continuous Flow Manufacturing Of Pharmaceutical Ingredients 11/25/2019

   Strong growth is anticipated for continuous flow manufacturing of APIs as it offers important advantages over traditional batch manufacturing in terms of quality, safety, and sustainability of the overall process.

5. Prioritize Safety And Mitigate Risk In HPAPI Manufacturing

   As highly potent active pharmaceutical ingredients become increasingly common across the industry, it is critical to work with partners who use a risk-based approach to ensure safety and quality.

6. Leveraging CDMOs In Pharma's Drive Toward Net Zero

   Environmental considerations in pharmaceutical manufacturing strategies have become increasingly important in the face of additional calls to address pollution and sustainability practices globally.

7. Implement A Risk-Based Approach To Safely Manufacture HPAPIs

   As interest in HPAPIs as powerful therapeutic mechanisms continues to grow, drug manufacturers must design thoughtful risk-based containment strategies to protect employees and ensure safety.

8. The Paradigm Shift To Continuous Flow Processes: A Holistic View

   Dr. Bert Metten, Tech. Dev. Manager at Ajinomoto Bio-Pharma Services, explores dangerous chemistries and continuous flow processes for the manufacture of safe, efficacious, cost-effective products.

9. Building A Greener Future With Sustainable Manufacturing Practices

   CDMOs across the pharmaceutical fine chemicals industry are considering how best to implement process adaptations, renewable raw materials, and green chemistry to reduce carbon footprints.

10. Rethinking Manufacturing Processes To Identify Green Opportunities

    Reducing the carbon footprint of your pharmaceutical fine chemicals manufacturing process requires a shift from the traditional process development approach. Sustainability requires revolutionary changes.